Christina (Tina) P./LinkedIn
Jun 21, 2026, 14:38
Christina (Tina) P: Staying Safe on Anticoagulation Therapy in Antiphospholipid Syndrome
Christina (Tina) P., CEO and Co-Founder of APS Foundation of America, shared on LinkedIn:
”Bleeding Risks and Blood Thinners: APS Awareness Day 21
Blood thinners (also called anticoagulants) are medicines that prevent blood clots.
They’re often used in conditions like Antiphospholipid Syndrome (APS) to reduce the risk of strokes, deep vein thrombosis (DVT), and other clot-related issues.
Blood thinners save lives by preventing dangerous clots — but they must be taken carefully to avoid serious bleeding.
Knowing the risks helps you stay safe and prepared.”
Stay updated with Hemostasis Today.
-
Sep 22, 2026, 09:18Shamee Shastry: How Transfusion Medicine Research Is Evolving in India
-
Sep 22, 2026, 09:11Tarique Shahzad Chachar: Why Warfarin Remains the Gold Standard for Mechanical Heart Valves
-
Sep 22, 2026, 09:04Bianca Rocca: Thromboinflammatory Injury in Ischemic Limb Necrosis During Severe Shock
-
Sep 22, 2026, 09:01Ash Paul: Comparing Left Atrial Appendage Occlusion and Oral Anticoagulation
-
Sep 22, 2026, 08:50Emily Horner: Lipoprotein(a) Links Oxidized Phospholipids to Platelet Hyperactivity
-
Sep 22, 2026, 08:42Sally Mandour: Bone Marrow Needle Gauge Explained
-
Sep 22, 2026, 08:39Alessandro Sionis: Navigating Anticoagulation in Mechanical Circulatory Support
-
Sep 22, 2026, 08:28Raghavendra Rao: The Latest Research on Varicose Veins
-
Sep 22, 2026, 08:23Aravind Palraj: Three Essential Tests in Antiphospholipid Syndrome